journal article·2020-07Open access

Enhancing the Efficacy of Metal‐Free MRI Contrast Agents via Conjugating Nitroxides onto PEGylated Cross‐Linked Poly(Carboxylate Ester)

Shiwei Guo, Xiaoming Wang, Yan Dai, Xinghang Dai, Zhiqian Li, Qiang Luo, Xiuli Zheng, Zhongwei Gu, Hu Zhang, Qiyong Gong, Kui Luo

Advanced Science· Volume 7· Issue 14

Abstract

Abstract Herein, two water‐soluble PROXYL‐based magnetic resonance imaging (MRI) macromolecular organic contrast agents (mORCAs) are designed and synthesized: linear and cross‐linked PCE‐mPEG‐Ppa‐PROXYL. They are prepared by conjugating linear and cross‐linked poly(carboxylate ester) (PCE) with poly(ethylene glycol) (mPEG2000)‐modified nitroxides (PROXYL), respectively. Both mORCAs form self‐assembled aggregates in an aqueous phase and PROXYL is protected inside a hydrophobic core to achieve great resistance to reduction in the physiological environment, and they have low toxicity. Since cross‐linked PCE‐mPEG‐Ppa‐PROXYL possess a branched architecture, its self‐assembled aggregate is more stable and compact with a greater particle size. Cross‐linked PCE‐mPEG‐Ppa‐PROXYL outperform the linear one in the following aspects: 1) its longitudinal relaxivity (r1 = 0.79 mm−1 s−1) is higher than that of the linear one (r1 = 0.64 mm−1 s−1) and both excel the best mORCA reported so far (r1 = 0.42 mm−1 s−1); 2) its blood retention time (≈48 h) is longer than that of its linear counterpart (≈10 h); 3) cross‐linked PCE‐mPEG‐Ppa‐PROXYL provided better MR imaging contrast resolution in normal organs (liver and kidney) and tumor of mice than the linear one. Overall, cross‐linked PCE‐mPEG‐Ppa‐PROXYL may have great potential to be a novel metal‐free macromolecular contrast agent for MR imaging.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Lanthanide and Transition Metal Complexes · Nanoplatforms for cancer theranostics · Nanoparticle-Based Drug Delivery

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Huaxi MR Research Center (HMRRC), Department of Radiology, Functional and molecular imaging Key Laboratory of Sichuan Province, National Clinical Research Center for Geriatrics, State Key Laboratory of Biotherapy, West China Hospital Sichuan University Chengdu 610041 P. R. China

Department of Pharmacy of the Affiliated Hospital of Southwest Medical University Southwest Medical University Luzhou Sichuan Province 646000 P. R. China

Department of Radiology, Chongqing General Hospital University of Chinese Academy of Sciences (UCAS) 104 Pipashan Zheng Street Chongqing 400014 P. R. China

West China School of Medicine Sichuan University Chengdu 610041 P. R. China

Amgen Bioprocessing Centre Keck Graduate Institute Claremont CA 91711 USA

Funding

National Natural Science Foundation of China · National Major Science and Technology Projects of China

References (51)

Show source-provided references
1. 10.1148/radiol.1515002510.1148/radiol.15150025 ↗
2. 10.1021/acsami.7b0649610.1021/acsami.7b06496 ↗
3. 10.1002/advs.20180002110.1002/advs.201800021 ↗
4. 10.1016/j.addr.2019.01.00510.1016/j.addr.2019.01.005 ↗
5. 10.1002/adma.20180316310.1002/adma.201803163 ↗
6. 10.1016/j.joca.2007.10.01510.1016/j.joca.2007.10.015 ↗
7. 10.1158/0008-5472.CAN-06-087910.1158/0008-5472.CAN-06-0879 ↗
8. 10.1016/j.apmt.2019.10052410.1016/j.apmt.2019.100524 ↗
9. 10.1016/j.redox.2015.10.00710.1016/j.redox.2015.10.007 ↗
10. 10.1080/10715762.2018.142723510.1080/10715762.2018.1427235 ↗
11. 10.1021/acscentsci.7b0025310.1021/acscentsci.7b00253 ↗
12. 10.1021/ol900157510.1021/ol9001575 ↗
13. 10.1021/jacs.8b0808110.1021/jacs.8b08081 ↗
14. 10.1080/10715762.2018.143726810.1080/10715762.2018.1437268 ↗
15. 10.1021/acsomega.9b0300310.1021/acsomega.9b03003 ↗
16. 10.1002/advs.20180180910.1002/advs.201801809 ↗
17. 10.1002/adma.20170745910.1002/adma.201707459 ↗
18. 10.1002/adma.20190679910.1002/adma.201906799 ↗
19. 10.1002/advs.20190121410.1002/advs.201901214 ↗
20. 10.1002/adfm.20180648510.1002/adfm.201806485 ↗
21. 10.1002/adfm.20190386010.1002/adfm.201903860 ↗
22. 10.1002/adma.20130522210.1002/adma.201305222 ↗
23. 10.1002/adfm.20120146910.1002/adfm.201201469 ↗
24. 10.1002/advs.20190324310.1002/advs.201903243 ↗
25. 10.1039/C7PY02001E10.1039/C7PY02001E ↗
26. 10.1088/1361-6528/ab062710.1088/1361-6528/ab0627 ↗
27. 10.1002/mrc.115110.1002/mrc.1151 ↗
28. 10.1021/ja307982910.1021/ja3079829 ↗
29. 10.1021/ja413028d10.1021/ja413028d ↗
30. 10.1038/ncomms646010.1038/ncomms6460 ↗
31. 10.1021/acsmacrolett.9b0001610.1021/acsmacrolett.9b00016 ↗
32. 10.1021/acsnano.8b0616010.1021/acsnano.8b06160 ↗
33. 10.1002/smll.20070059510.1002/smll.200700595 ↗
34. 10.1016/j.addr.2016.06.01610.1016/j.addr.2016.06.016 ↗
35. 10.1021/acs.chemmater.7b0197910.1021/acs.chemmater.7b01979 ↗
36. 10.1038/s41565-018-0085-310.1038/s41565-018-0085-3 ↗
37. 10.1021/acsmacrolett.6b0092410.1021/acsmacrolett.6b00924 ↗
38. 10.1039/C7PY00166E10.1039/C7PY00166E ↗
39. 10.1021/acsanm.8b0177410.1021/acsanm.8b01774 ↗
40. 10.1039/C6CS00550K10.1039/C6CS00550K ↗
41. 10.1002/chem.20190026210.1002/chem.201900262 ↗
42. 10.1002/anie.20181343410.1002/anie.201813434 ↗
43. 10.1021/acs.chemmater.9b0253010.1021/acs.chemmater.9b02530 ↗
44. 10.1002/adma.20170340410.1002/adma.201703404 ↗
45. 10.1038/s41467-018-07882-810.1038/s41467-018-07882-8 ↗
46. 10.1039/C7SC01447C10.1039/C7SC01447C ↗
47. 10.1002/adma.20180456710.1002/adma.201804567 ↗
48. 10.1002/adma.20190546110.1002/adma.201905461 ↗
49. 10.1038/s41565-019-0485-z10.1038/s41565-019-0485-z ↗
50. 10.1002/adma.20190749010.1002/adma.201907490 ↗
51. 10.1002/adma.20190158610.1002/adma.201901586 ↗